Trials / Completed
CompletedNCT01400854
Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
ERKENTNIS: Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Cephalon · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this non-interventional study is to investigate the tolerability of Effentora® in cancer pain patients with breakthrough pain under real-life conditions in clinical practice.
Detailed description
In addition to the effectiveness of Effentora® therapy, safety, general feasibility and the impact of therapy on the patients' quality of life are of interest.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Effentora® | prescribed as per local Summary of Product Characteristics (SmPC) for 4 weeks duration |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-07-22
- Last updated
- 2012-10-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01400854. Inclusion in this directory is not an endorsement.